Definitive Contract 75A50124C00027
Award Date
9/30/24
Potential Completion Date
12/31/26
Potential Value
$9.3M
Awardee
Revvity Health Sciences, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Hopkinton, MA 01748, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Pattern Bioscience, Inc., a biotechnology company, to develop a rapid pathogen identification and antimicrobial susceptibility testing platform. The contract, valued at $40,937,536.73, is for the verification, clinical evaluation, and U.S. Food and Drug Administration (FDA) clearance of this culture-free, phenotypic diagnostic platform. The contract is a...
This $34,714,763.00 cost-plus-fixed-fee contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Detect Inc. to advance the development of a second-generation, multi-analyte molecular SARS-CoV-2 and influenza A/B test that has a reduced time to result and increased sensitivity for use at home or in a point-of-care setting. The contract is not set aside. The award references a Broad Agency Announcement (BAA) issued by the Biomedical Advanced Research...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.) for $86,241.80. The contract is for the provision of PerkinElmer branded reagents and kits to support NIAID's Vaccine Research Center (VRC) and its work on therapeutic and vaccine candidates for diseases including COVID-19, HIV, influenza, malaria, and Ebola. The contract is not set aside...
This federal contract award, valued at $33,792,366.52, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Becton, Dickinson and Company (BD) for the production of multiplexed respiratory panel tests for the BD Veritor, BD MAX, and BD COR Systems. The contract, which has a completion date of June 30, 2027, is a definitive, firm-fixed-price contract and was not set aside for any specific socioeconomic category. The original solicitation was a Broad Agency...
This federal contract award, valued at $172,187.75, was issued by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc. (doing business as PerkinElmer Inc.). The contract is for the delivery of laboratory equipment and does not have a set-aside designation. Revvity Health Sciences, a for-profit manufacturer of medical imaging products and services, has previously received prime contract awards and subcontracts from various federal agencies, including the...
This is a $52,239,640.00 definitive contract awarded to Visby Medical, Inc. by the U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. The contract is for the delivery of a rapid, accurate, point-of-care disposable influenza and SARS-CoV-2 molecular diagnostic test. This award is not set aside for any particular business classification. The contract has an ultimate completion date of March 31, 2026. The original solicitation was issued...
This is a $17,325,268.78 cost-plus-fixed-fee contract awarded to Biofire Defense LLC on September 29, 2023 by the Office of the Assistant Secretary for Preparedness and Response (ASPR). The contract objective is to advance the development of Biofire's Emerging Flu Panel as a nucleic acid detection assay for use on the Biofire FilmArray Torch and Spotfire platforms. This work is related to a previous Broad Agency Announcement from the Biomedical Advanced Research and Development Authority (BARDA)...
This federal contract was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to 3M Company for research and development to increase the sensitivity and performance of at-home SARS-CoV-2 tests using the 3M Bioaerosol Sampling Device. The contract, valued at $749,998.90, is a definitive, firm-fixed-price contract with a completion date of February 29, 2024. The contract is not designated as a small business set-aside. 3M Company is a large,...
This is a $2,466,840.43 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Revvity Health Sciences, Inc., doing business as PerkinElmer Inc. The contract is for maintenance and service of PE (PerkinElmer) equipment. The contract has an ultimate completion date of May 31, 2027. Revvity Health Sciences, Inc. is a subsidiary of Revvity Inc., a for-profit manufacturer and service provider specializing in medical imaging products, laboratory...
This is a $38,900,000.00 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Hologic, Inc. to ensure test availability for SARS-CoV-2 after the emergency authorization closes. The purpose is for Hologic to submit an in vitro diagnostic (IVD) assay for SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) by September 30, 2027. This contract was awarded under a Broad Agency Announcement (BAA)...